driven by our ethos, the science of sure, we’re a diverse, dedicated, creative team that develops, markets and services some of the most innovative and accurate diagnostic imaging systems and surgical products on the planet. while we’re focused and passionate about our work, we never forget that what we’re really doing is giving people greater confidence and peace of mind in their diagnosis—enabling healthier lives, everywhere, every day. connect with us at hologic.com, on facebook at facebook.com/hologicjobs, and on twitter @hologic_jobs.
![Hologic logo](/files/LOGO/859737-HOLX.png)
Company profile
Ticker
HOLX
Exchange
Website
CEO
Stephen MacMillan
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Acessa Health Inc. • Beijing Hologic Technology Co., Ltd. • Benassar Diagnostica-Equipamientos Medicos Unipessoal, Lda. • BioLucent, LLC • Bioptics, Inc. • Biotheranostics, Inc. • Bolder Surgical Holdings, Inc. • Bolder Surgical, LLC • Cytyc Corporation • Cytyc Prenatal Products Corp. ...
IRS number
42902449
HOLX stock data
Latest filings (excl ownership)
SD
Conflict minerals disclosure
30 May 24
8-K/A
Hologic Announces Financial Results for Second Quarter of Fiscal 2024
3 May 24
10-Q
2024 Q2
Quarterly report
3 May 24
8-K
Hologic Announces Financial Results for Second Quarter of Fiscal 2024
2 May 24
8-K
Submission of Matters to a Vote of Security Holders
12 Mar 24
10-Q
2024 Q1
Quarterly report
2 Feb 24
8-K
Results of Operations and Financial Condition
1 Feb 24
DEFA14A
Additional proxy soliciting materials
18 Jan 24
DEF 14A
Definitive proxy
18 Jan 24
8-K
Departure of Directors or Certain Officers
12 Jan 24
Transcripts
HOLX
Earnings call transcript
2024 Q2
2 May 24
HOLX
Earnings call transcript
2024 Q1
1 Feb 24
HOLX
Earnings call transcript
2023 Q4
9 Nov 23
HOLX
Earnings call transcript
2023 Q3
31 Jul 23
HOLX
Earnings call transcript
2023 Q3
31 Jul 23
HOLX
Earnings call transcript
2023 Q2
25 Jul 23
HOLX
Earnings call transcript
2023 Q2
1 May 23
HOLX
Earnings call transcript
2023 Q1
1 Feb 23
HOLX
Earnings call transcript
2022 Q4
1 Nov 22
HOLX
Earnings call transcript
2022 Q3
28 Jul 22
Latest ownership filings
4
STEPHEN P MACMILLAN
19 Jul 24
4
Christiana Stamoulis
19 Jul 24
144
Notice of proposed sale of securities
17 Jul 24
144
Notice of proposed sale of securities
17 Jul 24
4
Brandon Schnittker
4 Jun 24
4
STEPHEN P MACMILLAN
24 May 24
4
STEPHEN P MACMILLAN
23 Apr 24
4
SCOTT T GARRETT
15 Mar 24
144
Notice of proposed sale of securities
14 Mar 24
4
Charles J Dockendorff
11 Mar 24
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jul 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Sep 23 | Sep 22 | Sep 21 | Sep 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 2.18 bn | 2.18 bn | 2.18 bn | 2.18 bn | 2.18 bn | 2.18 bn |
Cash burn (monthly) | (no burn) | 33.52 mm | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | n/a | 130.69 mm | n/a | n/a | n/a | n/a |
Cash remaining | n/a | 2.05 bn | n/a | n/a | n/a | n/a |
Runway (months of cash) | n/a | 61.1 | n/a | n/a | n/a | n/a |
Institutional ownership, Q1 2024
92.3% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 673 |
Opened positions | 182 |
Closed positions | 81 |
Increased positions | 200 |
Reduced positions | 209 |
13F shares | Current |
---|---|
Total value | 13.41 tn |
Total shares | 215.46 mm |
Total puts | 1.17 mm |
Total calls | 574.70 k |
Total put/call ratio | 2.0 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 26.79 mm | $2.09 tn |
BLK Blackrock | 23.39 mm | $1.82 tn |
T. Rowe Price Investment Management | 22.35 mm | $1.74 bn |
STT State Street | 10.47 mm | $816.57 bn |
T. Rowe Price | 6.30 mm | $490.93 mm |
Victory Capital Management | 5.70 mm | $444.27 bn |
Geode Capital Management | 5.53 mm | $429.75 bn |
MS Morgan Stanley | 4.79 mm | $373.46 bn |
MCQEF Macquarie | 4.11 mm | $320.04 bn |
AMP Ameriprise Financial | 3.51 mm | $273.33 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Jul 24 | Stamoulis Christiana | Common Stock | Sell | Dispose S | No | Yes | 79.5 | 9,039 | 718.60 k | 45,472 |
17 Jul 24 | Stamoulis Christiana | Common Stock | Option exercise | Acquire M | No | Yes | 26.74 | 9,039 | 241.70 k | 54,511 |
17 Jul 24 | Stamoulis Christiana | NQSO Common Stock | Option exercise | Dispose M | No | No | 26.74 | 9,039 | 241.70 k | 0 |
17 Jul 24 | Macmillan Stephen P | Common Stock | Sell | Dispose S | No | Yes | 80.126 | 3,672 | 294.22 k | 1,157,562 |
17 Jul 24 | Macmillan Stephen P | Common Stock | Option exercise | Acquire M | No | Yes | 26.21 | 3,672 | 96.24 k | 1,161,234 |
17 Jul 24 | Macmillan Stephen P | NQSO Common Stock | Option exercise | Dispose M | No | No | 26.21 | 3,672 | 96.24 k | 44,039 |
31 May 24 | Brandon Schnittker | Common Stock | Payment of exercise | Dispose F | No | No | 73.78 | 67 | 4.94 k | 4,211 |
23 May 24 | Macmillan Stephen P | Common Stock | Gift | Dispose G | No | No | 0 | 57,875 | 0.00 | 1,157,213 |
22 Apr 24 | Macmillan Stephen P | Common Stock | Gift | Dispose G | No | No | 0 | 12,000 | 0.00 | 1,215,088 |
19 Apr 24 | Macmillan Stephen P | Common Stock | Gift | Dispose G | No | No | 0 | 12,000 | 0.00 | 1,227,088 |
News
$1000 Invested In Hologic 10 Years Ago Would Be Worth This Much Today
25 Jul 24
Reasons to Add The Cooper Companies to Your Portfolio Now
24 Jul 24
Here's How Much $100 Invested In Hologic 20 Years Ago Would Be Worth Today
15 Jul 24
Buy 5 Medical Instruments Stocks to Enhance Your Portfolio
23 May 24
Hologic Recalls BioZorb Marker Due To Complications With Implanted Devices
22 May 24